Actuate Therapeutics Announces Closing Of $17.25 Million Public Offering Of Common Stock, Including Full Exercise Of Over-Allotment Option
Sept 11 (Reuters) - Actuate Therapeutics Inc ACTU.O:
ACTUATE THERAPEUTICS ANNOUNCES CLOSING OF $17.25 MILLION PUBLIC OFFERING OF COMMON STOCK, INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTION
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback

Nvidia Makes First Bet on Legal AI, Invests $50 Million in Legora

Palantir Q1 2026 Earnings Preview — Is PLTR a Buy at $144?

POET Technologies Stock Could Still Surge in 2026, but the Bar for a Breakout Is Higher Now

From Underdog to AI Infrastructure Leader: Is AMD Poised for Growth in 2026?

Tradingkey







